Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Census population 211,328. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Rochester clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Rochester storefront.
Skin Substitute Therapy Products in Rochester, NY for clinics & physicians. Skin substitute therapy for co… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. 10.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick skin substitute therapy against that mix.
National Skin Substitute Therapy Products notes (how the product actually works)JK reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Rochester is 14.3% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JK articles mapped. 10.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 14.3% of adults — 2.3 points above the U.S. 12% figure. Obesity is 38%; arthritis is 24.9%. That is place-level BRFSS modeling, not a clinic census and not a Rochester trial.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers skin substitute therapy products and which products they use.
Regulatory lane, storage, and JK coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Ask for the IFU, the lot-traceability packet, and the National Government Services (NGS) article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Rochester fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Rochester, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Rochester is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Rochester — 2.3 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Rochester. Useful for joint-program math; still needs a diagnosis and privileging.
No Rochester storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.